BioShuttle™
Revolutionizing Active Ingredient Delivery
BioShuttle™ is a groundbreaking delivery technology that enhances the absorption and effectiveness of active ingredients. By leveraging natural processes, BioShuttle™ safely transports compounds across the skin and can even reach the brain. BioShuttle™ is a safe, stable, and cost-effective solution for optimizing ingredient delivery.
Contact Us
Versatility and Efficiency
Targeted Delivery
Encapsulates active ingredients in stable, biocompatible nanoparticles for rapid delivery to target tissues.
Reduced Side Effects
Minimizes systemic exposure, enhancing safety profile of APIs.
Brain Delivery
Delivers APIs to the brain via the sinus, creating opportunities to treat intractable neurological disorders.
Rescuing Abandoned Active Ingredients
1
Identify
Target promising API candidates that were cancelled due to poor efficacy or adverse effects.
2
Remediate
Incorporate candidate APIs to enhance bioavailability, limit whole-body exposure and reduce dosing.
3
Revive
Create new revenue streams from previously abandoned assets.
Unparalleled Stability and Cost-Efficiency
Extended Shelf Life
BioShuttle™'s stabilized liposomes remain stable for up to two years at room temperature, far surpassing traditional liposomes.
Cost-Effective Solution
Minimal added cost per dose compared to other delivery technologies that can increase costs over 100-fold.
Enhanced Bioavailability and Lower Dosing
—
BioShuttle™ transforms active ingredient delivery with its natural enhancement of bioavailability. This leading-edge technology enables a dramatic reduction in the required levels of active ingredients—by 1,000 to 50,000 times compared to traditional methods. Discover the next-generation efficiency and safety of active ingredient delivery with BioShuttle™
Accelerated Product Development
1
Rapid Prototyping
Eliminates time-consuming bottlenecks in formulation development.
2
Faster Time-to-Market
Market-ready products can be developed in as little as 2 months, compared to the industry standard of 2+ years.
3
Agile Innovation
Streamlined development minimizes resource expenditure, reducing costs and increasing profitability.
Proven Success: 5 Proof-of-Concept Treatments
Obesity
Lipotope’s nasal formulation for weight management is designed to support healthy metabolism, balanced energy levels, and mindful eating habits. By leveraging advanced delivery technology, this formulation helps promote a feeling of fullness and encourages wellness-focused nutrition.
In an internal study, participants reported:
  • Feeling more in control of their snacking habits.
  • Making healthier food choices as part of a balanced lifestyle.
  • Improved energy levels and overall well-being.
Unlike traditional weight management options, this nasal formulation is non-invasive, easy to use, and designed for long-term wellness support. It is expected to launch in the UK market in 2025.
Pain
Lipotope's Pain Relief Topical Cream addresses various pain conditions, including arthritis, muscle aches, neuropathic pain, and chronic pain. Its natural ingredients reduce inflammation, block pain signals, and promote healing. Studies showed significant pain reduction, improved mobility, and reduced use of oral medications without adverse effects. The pain product is being introduced to the US in February of 2025 and the European and Australian markets in Q3, 2025.
Postmenopausal Intimacy
Lipotope has developed a topical formulation whose active ingredients promote lubrication, comfort, and intimate health. The cream is designed to address common challenges faced by post-menopausal women, such as vaginal dryness, discomfort, and decreased libido. Compared to traditional delivery modalities for the API, BioShuttle™-Intimacy reduces dosing and dramatically speeds the onset of action. The time to effect is changed from a week to less than an hour, making the act of intimacy less of a planned event for postmenopausal women. The product is planned for launch in the US in Q3 of 2025.
Anxiety-Induced Insomnia
Lipotope’s Nasal Spray is designed to support a sense of calm and relaxation, making it easier to unwind before bedtime. Participants in our internal study shared that they felt more at ease and refreshed after incorporating it into their nighttime routine. The formula is non-habit forming and designed to encourage a deeper, more refreshing sleep without grogginess. Planned introduction in the US market in 2025.
Athletic Performance/Recovery
Lipotope's topical athletic performance formulation can be administered prior to or after endurance-based or strenuous exercise. When used prior to endurance events, performance is enhanced by approximately 10% for amateur athletes. A further benefit is that DOMS (Delayed Onset Muscle Soreness) is either eliminated or significantly reduced. Planned introduction in the US market in 2025.
Partnership Opportunities
Distribution
Partner to distribute Lipotope's existing formulations.
Collaboration
Develop new formulations using the BioShuttle™ delivery platform.
Innovation
Unlock potential of existing APIs and create groundbreaking formulations.
Interested in partnering? Contact us at info@lipotope.net.